Clinical Trial Update: The Effect of PROCRIT (Epoetin Alfa) on Postoperative Vigor and Handgrip Strength (VIGOR Study) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating epoetin alfa (PROCRIT) on postoperative vigor and handgrip strength in patients with anemia. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Drugs mentioned

• PROCRIT (ERYTHROPOIETIN)

Snippet

Sponsor: Ortho Biotech, Inc. | Conditions: Anemia | Phase 4 | Status: COMPLETED